We are live on
!
Find out more
HF
HRT Financial Portfolio holdings
AUM
$40.1B
1-Year Est. Return
58.22%
This Fund
S&P 500
This Quarter
Est. Return
+7.21%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$8.2B
AUM Growth
+$1.12B
(+16%)
Cap. Flow
+$833M
Cap. Flow
% of AUM
10.16%
Top 10 Holdings %
Top 10 Hldgs %
26.95%
Holding
3,651
New
1,200
Increased
477
Reduced
532
Closed
1,218
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$289M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$179M |
| 3 |
Valero Energy
VLO
|
+$138M |
| 4 |
Linde
LIN
|
+$109M |
| 5 |
Eli Lilly
LLY
|
+$108M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$234M |
| 2 |
McKesson
MCK
|
+$118M |
| 3 |
Synopsys
SNPS
|
+$112M |
| 4 |
Tesla
TSLA
|
+$81.8M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$76.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.84% |
| 2 | Industrials | 10.46% |
| 3 | Healthcare | 9.19% |
| 4 | Financials | 8.96% |
| 5 | Consumer Discretionary | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
C4 Therapeutics
CCCC
$412M
| $375K | ﹤0.01% |
+119,612
| New | +$704K |
|
1577
M/I Homes
MHO
$3.84B
| $375K | ﹤0.01% |
+5,946
| New | +$342K |
|
1578
TXO Partners LP
TXO
$760M
| $375K | ﹤0.01% |
+16,247
| New | +$374K |
|
1579
Lineage Cell Therapeutics
LCTX
$278M
| $374K | ﹤0.01% |
249,380
+229,171
| +1,134% | +$320K |
|
1580
ALX Oncology
ALXO
$290M
| $373K | ﹤0.01% |
+82,545
| New | +$625K |
|
1581
Yum China
YUMC
$16.3B
| $373K | ﹤0.01% |
5,894
-128,008
| -96% | -$7.73M |
|
1582
Varex Imaging
VREX
$523M
| $371K | ﹤0.01% |
+20,417
| New | +$389K |
|
1583
PUT
Snowflake
SNOW
$115B
| $370K | ﹤0.01% |
2,400
-3,100
| -56% | -$454K |
|
1584
First Busey Corp
BUSE
$2.56B
| $369K | ﹤0.01% |
+18,161
| New | +$424K |
|
|
NGD
1585
DELISTED
New Gold Inc
NGD
| $369K | ﹤0.01% |
335,982
-282,635
| -46% | -$288K |
|
1586
AMERISAFE
AMSF
$540M
| $368K | ﹤0.01% |
7,526
-11,143
| -60% | -$584K |
|
1587
iShares MSCI United Kingdom ETF
EWU
$4.16B
| $368K | ﹤0.01% |
11,438
-24,038
| -68% | -$772K |
|
1588
PUT
JD.com
JD
$44.5B
| $368K | ﹤0.01% |
8,400
+4,400
| +110% | +$227K |
|
|
PBPB
1589
DELISTED
Potbelly
PBPB
| $368K | ﹤0.01% |
+44,293
| New | +$333K |
|
1590
The RMR Group
RMR
$332M
| $368K | ﹤0.01% |
14,030
+5,061
| +56% | +$142K |
|
1591
ANI Pharmaceuticals
ANIP
$1.78B
| $367K | ﹤0.01% |
+9,245
| New | +$390K |
|
1592
Schrodinger
SDGR
$1.36B
| $365K | ﹤0.01% |
+13,889
| New | +$330K |
|
1593
CALL
lululemon athletica
LULU
$14.6B
| $364K | ﹤0.01% |
+1,000
| New | +$314K |
|
1594
CALL
Pinduoduo
PDD
$131B
| $364K | ﹤0.01% |
4,800
-6,100
| -56% | -$551K |
|
1595
ProQR Therapeutics
PRQR
$265M
| $364K | ﹤0.01% |
+171,306
| New | +$524K |
|
1596
Nexa Resources
NEXA
$1.87B
| $363K | ﹤0.01% |
57,835
+1,671
| +3% | +$10.8K |
|
1597
News Corp Class A
NWSA
$15.4B
| $363K | ﹤0.01% |
21,025
+5,842
| +38% | +$107K |
|
|
TBNK
1598
DELISTED
Territorial Bancorp Inc.
TBNK
| $363K | ﹤0.01% |
+18,813
| New | +$430K |
|
|
BMAC
1599
DELISTED
Black Mountain Acquisition Corp.
BMAC
| $363K | ﹤0.01% |
35,012
| – | – |
|
1600
BlackSky Technology
BKSY
$1.19B
| $361K | ﹤0.01% |
+30,163
| New | +$407K |
|
Similar funds
DB
HRT Financial's Q1 2023 Portfolio in Review
As of Q1 2023, HRT Financial held 3,651 positions worth $8.2B, up 16% from $7.07B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
HRT Financial deployed $833M of net new capital in Q1 2023, opening 1,200 new positions and adding to 477 existing holdings. Its largest new stake was Valero Energy: 1,028,681 shares worth $144M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 18% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was McKesson, an estimated $118M trimmed.
- HRT Financial's largest Q1 2023 buy was Valero Energy: 1,028,681 shares worth $144M.
- HRT Financial added most to Invesco QQQ Trust in Q1 2023, an estimated $289M increase.
- HRT Financial's biggest Q1 2023 reduction was McKesson, cutting an estimated $118M.
- HRT Financial fully exited Apple in Q1 2023, selling an estimated $234M.
- HRT Financial's ten largest holdings make up 27% of its $8.2B portfolio in Q1 2023.
- HRT Financial opened 1,200 new positions and closed 1,218 in Q1 2023.
- HRT Financial's portfolio value rose 16% quarter-over-quarter to $8.2B.
Based on HRT Financial's 13F filing for Q1 2023, filed 12 May 2023.